Furthermore, PIM kinase family was associated with the commonly mutated genes in DLBCL, such as MYD88, MYC, and BTK, which provides additional evidence that PIM kinase family may serve as targeted agents for DLBCL. Here, MYC is linked to diffuse large B-cell lymphoma.